Loeffert, S. T. et al. Investigation of the Relationships Between Clinical and Environmental Isolates of Aspergillus fumigatus by Multiple-locus Variable Number Tandem Repeat Analysis During Major Demolition Work in a French Hospital. Clin. Infect. Dis. 68, 321–329 (2019).

Espinel-Ingroff, A. et al. Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values. Antimicrob. Agents Chemother. 62, e01916-17 (2018).

Schwarz, C. et al. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis. Med. Mycol. 56, 42–59 (2018).

Morio, F. et al. PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR34 /L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis. Mycoses 61, 30–34 (2018).

Melloul, E. et al. Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: Does the Strain Matter? Front. Microbiol. 9, 2850 (2018).

Delhaes, L. et al. Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP” J. Cyst. Fibros. (2018). doi:10.1016/j.jcf.2018.10.001

Raffetin, A., Courbin, V., Jullien, V. & Dannaoui, E. In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp. Antimicrob. Agents Chemother. 62, (2018).

Fakhim, H. et al. In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions. Diagn. Microbiol. Infect. Dis. 91, 266–268 (2018).

Aït-Ammar, N. et al. Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients. BMC Infect. Dis. 18, 648 (2018).

Imbert, S. et al. Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study. Antimicrob. Agents Chemother. 62, e02315-17 (2018).

Vaezi, A. et al. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex. Mycoses 61, 134–142 (2018).

Cadoré, J.-L., Guillot, J., Bourdoiseau, G. & Leroux, C. Guttural pouch diseases in horses: A challenging differential diagnosis. Equine Vet. Educ. (2018). doi:10.1111/eve.12977

Angebault, C. et al. Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols. PLoS One 13, e0201174 (2018).

Espinel-Ingroff, A. et al. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods. Antimicrob. Agents Chemother. 63, (2018).

Decousser, J.-W., Woerther, P.-L., Soussy, C.-J., Fines-Guyon, M. & Dowzicky, M. J. The Tigecycline Evaluation and Surveillance Trial; assessment of the activity of tigecycline and other selected antibiotics against Gram-positive and Gram-negative pathogens from France collected between 2004 and 2016. Antimicrob. Resist. Infect. Control 7, 68 (2018).

Botterel, F. et al. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory. Mycopathologia 183, 171–183 (2018).

Espinel-Ingroff, A. et al. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method. Antimicrob. Agents Chemother. 61, (2017).

Loeffert, S. T. et al. Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study. BMJ Open 7, e018109 (2017).

Toussaint, B. et al. An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1046, 26–33 (2017).

Dannaoui, E. et al. Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit. J. Clin. Microbiol. 55, 3210–3218 (2017).

Levesque, E. et al. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients. Int. J. Mol. Sci. 18, 862 (2017).

Melloul, E. et al. Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm. PLoS One 11, e0166325 (2016).

Gresnigt, M. S. et al. Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor. Sci. Rep. 6, 26490 (2016).

Greppi, M. C. et al. Experimental induction of mycotic plaques in the guttural pouches of horses. Med. Mycol. 55, myw073 (2016).

Cabaret, O. et al. Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease? J. Med. Microbiol. 65, 414–9 (2016).

Contou, D. et al. Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study. Ann. Intensive Care 6, 52 (2016).

Choukri, F. et al. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France. Med. Mycol. 53, 593–6 (2015).

Irinyi, L. et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med. Mycol. 53, 313–337 (2015).

van der Linden, J. W. M. et al. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg. Infect. Dis. 21, 1041–4 (2015).

Garcia-Hermoso, D. et al. High diversity of non-sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis? Mycoses 58, 557–64 (2015).

Imbert, S. et al. In vitro combination of voriconazole and miltefosine against clinically relevant molds. Antimicrob. Agents Chemother. 58, 6996–8 (2014).

Cabaret, O., Puel, O., Botterel, F., Delaforge, M. & Bretagne, S. Metabolic detoxification pathways for 5-methoxy-sterigmatocystin in primary tracheal epithelial cells. Xenobiotica. 44, 1–9 (2014).

Melloul, E. et al. Assessment of Aspergillus fumigatus burden in lungs of intratracheally-challenged turkeys (Meleagris gallopavo) by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Comp. Immunol. Microbiol. Infect. Dis. 37, 271–279 (2014).

Wang, D. Y. et al. Mutations in the Cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus isolated from avian farms in France and China. Poult. Sci. 93, 12–5 (2014).

Thierry, S. et al. Assessment of Aspergillus fumigatus pathogenicity in aerosol-challenged chickens (Gallus gallus) belonging to two lineages. Comp. Immunol. Microbiol. Infect. Dis. 36, 379–385 (2013).